Table 1.
Baseline characteristics of the included studies.
| References | Country | Diagnosis | Experimental | Control | Course | Type of outcomes | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment | n | Age (Mean ± sd) | Treatment | n | Age (Mean ± sd) | |||||
| Bai et al. 2023 (49) | China | POI | ACU+MOX | 30 | 31.40 ± 3.60 | Climen | 15 | 30.80 ± 5.50 | 12w | ①②③④ |
| Bai et al. 2023 (49) | China | POI | ACU | 30 | 32.60 ± 5.80 | Climen | 15 | 30.80 ± 5.50 | 12w | ①②③④ |
| Dong 2021 (50) | China | DOR | ACE | 19 | 34.00 ± 4.04 | Femoston | 18 | 34.17 ± 5.03 | 12w | ③⑤ |
| Du et al. 2022 (51) | China | POF | ACU+EA+MOX | 40 | 32.50 ± 4.60 | Progynova | 40 | 32.00 ± 4.50 | 12w | ①④ |
| Liu 2021 (52) | China | POI | ACU+EA | 21 | 34.36 ± 5.57 | Femoston | 22 | 34.44 ± 6.34 | 12w | ①④ |
| Luo et al. 2024 (95) | China | DOR | EA | 30 | 34.67 ± 2.97 | Femoston | 30 | 34.47 ± 3.22 | 12w | ①②⑤ |
| Shi 2022 (53) | China | POI | ACE | 30 | 31.60 ± 5.07 | Femoston | 30 | 32.16 ± 4.68 | 12w | ①②⑤ |
| Sun 2023 (54) | China | DOR | ACU+MOX | 30 | 34.20 ± 2.64 | Femoston | 30 | 34.57 ± 3.29 | 12w | ①⑤ |
| Xu et al. 2021 (55) | China | POI | ACU | 30 | 31.00 ± 4.00 | Climen | 30 | 29.00 ± 5.00 | 12w | ①④ |
| Xu 2023 (56) | China | DOR | ACU+EA+MOX | 24 | NR | Femoston | 24 | NR | 8w | ①②⑤ |
| Xu et al. 2023 (57) | China | DOR | ACU+EA+MOX | 16 | 31.63 ± 4.29 | Femoston | 16 | 30.88 ± 4.27 | 8w | ①② |
| Yue et al. 2023 (58) | China | POI | ACU+EA | 75 | 32.15 ± 5.02 | Femoston | 75 | 31.89 ± 4.87 | 12w | ①②④⑤ |
| Zhao 2024 (96) | China | DOR | MOX | 30 | 36.93 ± 4.68 | Femoston | 30 | 36.23 ± 4.58 | 12w | ①⑤ |
ACU, acupuncture; EA, electroacupuncture; MOX, moxibustion; ACE, acupoint catgut embedding; NR, No reported; W, week. ①SAS; ②SDS; ③HAMA; ④Kupperman Index; ⑤Integrals of TCM syndromes. Climen, compound packaging of estradiol valerate tablets(2mg)/estradiol cyproterone tablets(2mg:1mg); Femoston, compound packaging of estradiol valerate tablets(2mg)/estradiol cyproterone tablets(2mg:10mg); progynova, estradiol valerate tablets(1mg).